Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Evaluation of ChatGPT as a Reliable Source of Medical Information on Prostate Cancer for Patients: Global Comparative Survey of Medical Oncologists and Urologists
3
Zitationen
14
Autoren
2024
Jahr
Abstract
INTRODUCTION: No consensus exists on performance standards for evaluation of generative artificial intelligence (AI) to generate medical responses. The purpose of this study was the assessment of Chat Generative Pre-trained Transformer (ChatGPT) to address medical questions in prostate cancer. METHODS: < .05. RESULTS: < .05). Despite favoring AI-generated responses when blinded to questions/answers, respondents considered medical websites a more credible source (52%-67%) than ChatGPT (14%). Respondents in component 2 (N = 98) also considered medical websites more credible than ChatGPT, but rated AI-generated responses highly for all evaluation criteria, despite nuanced answers in the medical literature. CONCLUSIONS: These findings provide insight into how clinicians rate AI-generated and MW-curated responses with evaluation criteria that can be used in future AI validation studies.
Ähnliche Arbeiten
Explainable Artificial Intelligence (XAI): Concepts, taxonomies, opportunities and challenges toward responsible AI
2019 · 8.693 Zit.
Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead
2019 · 8.598 Zit.
High-performance medicine: the convergence of human and artificial intelligence
2018 · 8.124 Zit.
BioBERT: a pre-trained biomedical language representation model for biomedical text mining
2019 · 6.871 Zit.
Proceedings of the 19th International Joint Conference on Artificial Intelligence
2005 · 5.781 Zit.
Autoren
Institutionen
- University of Tübingen(DE)
- Duke Cancer Institute
- Duke Medical Center(US)
- University Hospital Galway(IE)
- Pfizer (United States)(US)
- Institut Paoli-Calmettes(FR)
- University of British Columbia(CA)
- Weill Cornell Medicine(US)
- Cornell University(US)
- Lander Institute(IL)
- Pfizer (France)(FR)
- Presbyterian Hospital(US)